Rosetta Genomics
Biotechnology Research51-200 Employees
Rosetta Genomics' integrative research platform combining bioinformatics and state-of-the art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Rosetta develops and commercializes a range of proprietary microRNA-based tests, including RosettaGX Reveal (Thyroid microRNA Classifier) and RosettaGX Cancer Origin, as well as other molecular diagnostic assays. The company also offers core FISH, IHC and PCR-based testing capabilities and partnerships in pathology, endocrinology, oncology and urology. Rosetta’s cancer testing services are commercially available through its Philadelphia, PA- and Lake Forest, CA-based CAP-accredited, CLIA-certified labs. To Learn More, Visit: www.rosettagx.com